GlassScriptPhysician profile
George Barnes
NPI 1144293119
$947.76
in general payments reported to CMS, 2019-2025
15 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $60.53 · 2021: $188 · 2022: $46.23 · 2023: $116 · 2024: $260 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489 · Education: $51.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.74 |
| Education | $51.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $309.28 | 2019-2025 | Nuzyra |
| Smith+Nephew, INC. | $178.51 | 2019-2025 | Collagenase Santyl, Grafix |
| Kerecis Limited | $69.93 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Misonix INC | $67.99 | 2021 | |
| Organogenesis INC. | $45.86 | 2019-2021 | |
| Theratechnologies INC. | $37.44 | 2019 | |
| Kci USA, INC. | $33.35 | 2021 | |
| Bioventus LLC | $33.35 | 2022 | |
| Tactile Systems Technology INC | $32.54 | 2019-2020 | |
| Integra Lifesciences Corporation | $30.11 | 2025 | Tcc-Ez |
| Mimedx Group, INC. | $29.41 | 2025 | |
| Next Science LLC | $29.16 | 2023 | Xperience, Surgx, Blastx |
| Lifenet Health | $26.54 | 2025 | Theragenesis Wound Matrix |
| Convatec INC. | $12.52 | 2019 | |
| Boston Scientific Corporation | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.